Trial intelligence / Profile preview

Niacinamide vs Desonide for Axillary Hyperpigmentation

NCT01542138Phase 4Completed

Sponsor
Universidad Autónoma de San Luis Potosí
Start
Jul 2011
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of nicotinamide in Hyperpigmentation, sponsored by Universidad Autónoma de San Luis Potosí. Primary endpoint: Pigmentation at 9 weeks. Started Jul 2011; status: completed.

02

Drugs

nicotinamide
03

Conditions

Hyperpigmentation

Beyond the preview

Go deeper on NCT01542138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01542138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call